Conversely, in our study we analyzed only patients with locally advanced or metastatic NSCLC, a choice that reflects the real population to which immunotherapy is addressed, even if in the most cases these patients were not submitted to surgery and therefore, PD-L1 expression obtained on biopsy sample could not reflect its real expression. The gene discussed is CD274; the disease is non-small cell lung carcinoma.